Search

Bio Roundup: Moderna's IPO, Arena's Comeback, E-Cig Survey & More

BIO ROUNDUP: MODERNA'S IPO, ARENA'S COMEBACK, E-CIG SURVEY & MORE

Thanksgiving is around the corner and this week delivered a bounty of deals that have a number of life science companies expressing...

BIO Celebrates 300 Biotech IPOs since Enactment of the JOBS Act

BIO CELEBRATES 300 BIOTECH IPOS SINCE ENACTMENT OF THE JOBS ACT

The biotech industry recently realized its 300 th IPO since the Jumpstart Our Business Startups Act was enacted in 2012. This marks...

 
 
 
 
 
 
Support your immune system with Bio-Tech Vitamin D

SUPPORT YOUR IMMUNE SYSTEM WITH BIO-TECH VITAMIN D

The children are back in school, temperatures are dropping, and the days are getting shorter. Optimal nutrition is more important than...

Major Study Positive on Chelation Therapy for Heart Disease

MAJOR STUDY POSITIVE ON CHELATION THERAPY FOR HEART DISEASE

Los Angeles, CA: Chelation therapy for heart and vascular disease is an exciting but controversial alternative therapy that has been...

 
 
 
Food For Thought: Good Nutrition for the Brain

FOOD FOR THOUGHT: GOOD NUTRITION FOR THE BRAIN

Dr. Karen Dees Are you getting proper nutrition for your brain? The human brain is only 2 % of the total body weight, yet it needs...

Opportunities for Patient and Health Advocates

OPPORTUNITIES FOR PATIENT AND HEALTH ADVOCATES

Last week, the seventh annual Patient and Health Advocacy Summit brought hundreds of patient advocates, industry experts and policymakers...

 
 
 
BIO Patient & Health Advocacy Summit Concludes Today

BIO PATIENT & HEALTH ADVOCACY SUMMIT CONCLUDES TODAY

Each year BIO brings the patient stakeholder community together for the BIO Patient and Health Advocacy Summit to network; to learn;...

 
 
 
Bio Roundup: Alzheimer's Puzzle, ESMO Assessed, Drug Prices & More

BIO ROUNDUP: ALZHEIMER'S PUZZLE, ESMO ASSESSED, DRUG PRICES & MORE

In the biotech investment and research communities this week, much of the attention was turned to Europe. Munich, Germany, hosted the...

 
 
 
Bio Roundup: Prices on TV, Novartis Hearts Radio, Warp Drive's End

BIO ROUNDUP: PRICES ON TV, NOVARTIS HEARTS RADIO, WARP DRIVE'S END

Two new battlegrounds emerged this week in the nation's ongoing drug pricing debate. The first involved television: The federal government...

BIO Investor Forum Explores “Digiceuticals” as a New Class of FDA-Approved Therapeutics

BIO INVESTOR FORUM EXPLORES “DIGICEUTICALS” AS A NEW CLASS OF FDA-APPROVED THERAPEUTICS

Within the past year, the FDA has launched a provider pre-certification program as a pilot to manage the expansion of “digiceuticals”...

 
 
 
2018 BIO Investor Forum Wraps Up

2018 BIO INVESTOR FORUM WRAPS UP

As the stock market continued its volatile swings this week, investors at the BIO Investor Forum -which wrapped up today in San Francisco-seemed...

Lessons from “View from the Board: Responding to an Acquisition Offer”

LESSONS FROM “VIEW FROM THE BOARD: RESPONDING TO AN ACQUISITION OFFER”

The “View from the Board: Responding to an Acquisition Offer” panel at the 2018 BIO Investor Forum focused on real world scenarios...

 
 
 
On Track for a Record Breaking 2018 - BIF18 Opening Plenary

ON TRACK FOR A RECORD BREAKING 2018 - BIF18 OPENING PLENARY

Despite some recent market volatility, the industry is well positioned for long-term growth and success. That was the underlying theme...

How Companies are Using Microbiome-Based Therapies to Improve Patient Outcomes

HOW COMPANIES ARE USING MICROBIOME-BASED THERAPIES TO IMPROVE PATIENT OUTCOMES

On Wednesday morning at the BIO Investor Forum , leaders from six companies at the forefront of microbiome innovation assembled to...

 
 
 
Warp Drive's Odyssey Ends with a Buyout-By Revolution, Not Sanofi

WARP DRIVE'S ODYSSEY ENDS WITH A BUYOUT-BY REVOLUTION, NOT SANOFI

Warp Drive Bio started up in 2012 with a potential buyer, Sanofi, already in place. Six years later the Cambridge, MA, company is being...